Developing antigen-specific therapies in multiple sclerosis: a tale of Tantalus or Ulysses?

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.8, Iss.10, 1999-10, pp. : 1537-1550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antigen-specific therapies in multiple sclerosis

By Giacomini Paul S Bar-Or Amit

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 3, 2009-09 ,pp. : 551-560

Informa Healthcare

Access to resources Recommend Favorite

Antigen-specific tolerization approaches in multiple sclerosis

By Lutterotti Andreas Martin Roland

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 9-20

Informa Healthcare

Access to resources Recommend Favorite

Emerging therapies in multiple sclerosis

By Farrell Rachel Heaney Dominic Giovannoni Gavin

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 797-816

Informa Healthcare

Access to resources Recommend Favorite

Induction and Escalation Therapies in Multiple Sclerosis

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 14, Iss. 1, 2015-03 ,pp. : 26-34

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging disease modifying therapies for multiple sclerosis

By Waubant Emmanuelle

Expert Opinion on Emerging Drugs, Vol. 8, Iss. 1, 2003-05 ,pp. : 145-161

Informa Healthcare

Access to resources Recommend Favorite